abstract: Oocyte cytoplasmic maturation is influenced by the quantity of synthesized RNA and proteins accumulated and stored during growth. Transcriptional repression and degradation of transcripts occur during oocyte nuclear maturation, and prolonged transcriptional arrest might compromise RNA stores for early development. RNA quantification of key genes in oocytes might be valuable when setting up in vitro cultures that lack the normal hormonal interplay found in vivo. This study quantifies gene expression levels in relation to follicle culture time and time of oocyte maturation in a mouse model. RNA levels of Gdf-9, Bmp-15, Mater, Zar-1, Npm-2 and Fgf-8 were measured in germinal vesicle oocytes along fixed times during in vitro follicle development. For all genes, the highest mRNA levels were detected in oocytes in the pre-antral follicle stage. Antrum formation was associated with a progressive shutdown in transcription leading to mRNA values lower than those in vivo preovulatory oocytes by extending period of in vitro culture. In contrast to in vitro-matured oocytes, the in vivo oocytes from 22-and 29-day-old prepubertal animals obtained after pregnant mare's serum gonadotrophin and human chorionic gonadotrophin priming did not down-regulate transcripts upon maturation stimulus except for Mater. These findings show that oocyte gene expression patterns under in vitro conditions can, at certain times, mimic what is reported to occur under in vivo conditions. Moreover, they also show that meiotically competent oocytes kept in a prolonged transcriptionally inactive stage express altered levels of key transcripts compared with in vivo in both immature and mature oocytes.
Introduction
Oocyte developmental competence is defined as the oocyte's potential to undergo maturation, fertilization, development into the blastocyst stage and as a final outcome to give rise to live offspring (Trounson et al., 2001; Sirard et al., 2006) . Competence is gained gradually during folliculogenesis and oocyte growth. During the growth period, the oocyte synthesizes and accumulates the RNAs and proteins that are vital for its appropriate growth and maturation and indispensable for the development into a viable embryo (Eichenlaub-Ritter and Peschke, 2002; Lonergan et al., 2003) . Synthesis of transcripts is highest in the earliest phases of development; however, at the end of growth and before oocyte maturation, transcriptional activity essentially ceases (Bachvarova, 1985; De La Fuente et al., 2004) . Moreover, a degradation of most oocyte transcripts is known to occur during resumption of meiosis, as reported for mouse (Bachvarova, 1985; De La Fuente et al., 2004; Su et al., 2007) , cow (Lonergan et al., 2003; Lequarre et al., 2004; Fair et al., 2007) and human (Jones et al., 2008) .
Oocyte meiotic competence, which is the ability to resume meiosis, is acquired during the transition from secondary follicle to small antral follicle (mouse; Sorensen and Wassarman, 1976; Wickramasinghe et al., 1991; bovine; Sirard et al., 2006) , whereas developmental competence is attained during the transition from small to large antral follicle stage in mouse and cow (Eppig and Schroeder, 1989; Sirard et al., 2006) . It has been shown that the interaction between the mammalian oocyte and its surrounding somatic cells is important from the earliest stages and contributes to normal oocyte development and cumulus cell differentiation (Buccione et al., 1990; Gilchrist et al., 2004; Eppig et al., 2005; Sugiura et al., 2005; Diaz et al., 2006; Diaz et al., 2007) . Cumulus cells provide the oocyte with nutrients and regulatory signals essential to promote oocyte nuclear and cytoplasmic maturation. This, together with the correct gene expression patterns, is crucial for the acquisition of oocyte developmental competence (Gilchrist et al., 1997; De La Fuente and Eppig, 2001; Eichenlaub-Ritter and Peschke, 2002; Krisher, 2004; Hussein et al., 2006; Sirard et al., 2006) .
Oocyte-specific gene products are known to play important roles during folliculogenesis and oocyte maturation. Oocyte secreted factors, such as Gdf-9 (growth differentiation factor 9), Bmp-15 (bone morphogenetic protein 15), can regulate granulosa cell functions such as proliferation, differentiation and cumulus expansion, as demonstrated in mice and bovine (Elvin et al., 1999; Eppig, 2001; Richards et al., 2002; Gilchrist et al., 2004; Hussein et al., 2006; Su et al., 2008) . Oocyte genes, such as Mater (maternal antigen that embryo requires), Zar-1 (zygotic arrest 1) and Npm-2 (nucleoplasmin) (Tong et al., 2000; Burns et al., 2003; Wu et al., 2003a, b) also play vital roles during the first stages of embryo development, and the absence of their protein products in the mouse oocyte has a direct impact on the cleavage potential and on the progression of the embryo beyond the blastocyst stage.
A microarray analysis on isolated mouse oocytes demonstrated that a great number of gene transcripts are present in oocytes throughout their development (from primordial follicle to large antral stage). Furthermore, around 10 000 genes are expressed during the antral phase, of which 15% are regulated between small and large antral follicles (Pan et al., 2005) . Active regulation of some of these genes, until the last stages of pre-ovulatory development, still needs to be confirmed, for example, by making use of a well-controlled in vitro culture system.
Follicle culture and in vitro maturation (IVM) are tentative techniques to preserve oocytes in patients with premature ovarian failure and to avoid side effects of hormonal stimulation protocols in some patients undergoing assisted reproduction techniques, respectively. These techniques are valuable not only because they allow the production of large numbers of oocytes, but also because they provide a valuable model to study critical interactions regulating oocyte development and factors controlling gene expression at different developmental stages.
Immature mouse oocytes from early pre-antral follicles can be grown in synchrony up to meiotically competent oocytes by means of a follicle culture system (Cortvrindt et al., 1996; Eppig and O'Brien, 1996) . Similarly, culture systems that support early development of human primordial follicles up to the secondary follicle stage (Hovatta et al., 1999) and antral follicle stage have been developed (Telfer et al., 2008) , although optimization to achieve fully grown human oocytes is still needed. Moreover, models for IVM of human oocytes have also been developed (Cha et al., 1991; Trounson et al., 1994; Cha and Chian, 1998) . Recently, by using an IVM system, minimal effects on the long-term health of mice offspring have been evidenced, demonstrating that the use of these techniques may be safe for clinical applications (Eppig et al., 2009) . Developmental competence of oocytes developed under in vitro environments, however, remains lower when compared with their in vivo counterparts (Eppig and O'Brien, 1996; Trounson et al., 2001; Smitz and Cortvrindt, 2002; Kim et al., 2004; Combelles et al., 2005; Anckaert et al., 2009) . Lower developmental competence of in vitro-matured oocytes has been related to the inadequacy of the in vitro environment (Rizos et al., 2002) , leading to the altered composition and abundance of specific transcripts in oocyte mRNA pools (bovine; De Sousa et al., 1998; Watson et al., 2000) or the absence of specific proteins in cultured oocytes (human; Trounson et al., 2001; bovine; Lonergan et al., 2003; Sirard et al., 2006) . In addition, human oocytes show a dysregulation in gene transcription after IVM, which may explain their lower developmental competence (Jones et al., 2008) . So far, there is little quantitative information regarding oocyte transcript levels and how these vary under the influence of the follicular environment and the long-term in vitro culture conditions. In addition, the knowledge on the expression patterns of the transcripts that are important for the acquisition of oocyte developmental competence may ultimately help to improve culture conditions.
Oocyte-specific genes analyzed here were chosen on the basis of the essential roles they play in the events of mouse oocyte development and maturation: Gdf-9, Bmp-15 and Fgf-8 (fibroblast growth factor 8) (McGrath et al., 1995; Valve et al., 1997; Dube et al., 1998; Carabatsos et al., 1998 , Otsuka et al., 2000 Yan et al., 2001; Rajkovic and Matzuk, 2002; Wu and Matzuk, 2002; Gui and Joyce, 2005) . Three other genes selected are maternal-effect genes coding for factors that the embryo inherits from the oocyte and that are essential for appropriate early embryo development: Mater, Zar-1 and Npm-2 (Tong et al., 2000; Burns et al., 2003; Wu et al., 2003a, b; Uzbekova et al., 2006) .
Our primary aim was to study the mRNA abundance of these genes at late pre-antral and antral follicle stages. Transcript abundance was compared between nuclear-competent in vitro and in vivo grown germinal vesicle (GV) oocytes. Effects of nuclear maturation on gene expression levels between in vitro and in vivo oocytes were also analyzed and compared.
Materials and Methods

Animal model
All animals used in this study were treated in accordance with the national legislation and the consent of the committee for animal experimentation of the Vrije Universiteit Brussel (Project No. 01-395-1).
Oocyte collection for gene expression during in vitro growth
Follicle culture
As a first experiment, ovarian pre-antral follicles from 13-day-old mice (F1 hybrids: c57Bl/6J Â CBA/ca) were isolated and cultured as described previously . Briefly, aseptically dissected ovaries were placed in medium Leibovitz L-15 (Invitrogen) containing 10% heat-inactivated fetal bovine serum (FBS; Invitrogen, Merelbeke, Belgium), 100 IU/ml penicillin, 100 mg/ml streptomycin (Penicillin/ Streptomycin-Mix, Invitrogen). Only follicles with diameters between 110 and 130 mm were isolated, individually transferred to 96-well microtiter plates (Costar, Elscolab, Kruibeke, Belgium) and cultured for 12 days under the following conditions: 378C, 5% CO 2, 100% humidity. Culture medium consisted of a-MEM glutamax (Invitrogen), 5% FBS, 5 mg/ml insulin, 5 mg/ml transferrin and 5 ng/ml sodium selenite (ITS, Sigma, Bornem, Belgium), 10 mIU/ml r-FSH and 10 mIU/ml r-LH (added once at the beginning of culture) (both from Ares-Serono, Geneva, Switzerland). Follicles were cultured in 75 ml of culture medium refreshed every 4 days by replacing 30 ml of spent by fresh medium. On Day 12 of culture, ovulation was induced by the addition of 1.2 IU/ml human chorionic gonadotrophin (hCG) (Ares-Serono) plus 0.65 nM recombinant human epidermal growth factor (EGF; Roche Diagnostics, Mannheim, Germany). Ovulation was induced only in follicles serving as control of culture conditions. Extrusion of polar body was assessed 16 h after stimulation.
During in vitro growth, the follicles develop from the pre-antral to the antral stage (Fig. 1) . Within the first 6 days of culture, pre-antral follicles lose their round shape (granulosa cells outgrow the basal membrane and colonize the bottom of the plate) and acquire a 'diffuse appearance' ('D' follicles). From Day 6, the formation of an antral-like cavity starts ('D/A' follicles) and by Day 8, most follicles complete the formation of this cavity and become antral ('A' follicles). Fully grown antral follicles ready to ovulate are obtained after 12 days of culture.
Oocyte collection
Oocytes at the GV stage were collected at different stages of in vitro development: Days 6, 8, 10, 12 and 14 of follicle culture (Fig. 1) . On Day 6, oocytes were collected from diffuse (D) and diffuse-antral (D/A) stages. From Day 8 onwards, oocytes were collected from follicles at diffuseantral (D/A) or antral (A) stage. Day-14 oocytes were collected as a model for oocytes that have resided too long in the follicle and have reduced meiotic competence as proven previously . Oocytes were first denuded by repeated pipetting with a fine glass pipette attached to a mouth piece and washed thoroughly in refreshment medium. Oocyte diameter (excluding the zona pellucida) was recorded at every time point. Oocytes from stimulated adult 9-week-old female mice were collected 48 h after eCG priming (5 IU Folligon w from Intervet, Oss, The Netherlands; intraperitoneal) and included as reference to compare gene expression levels in meiotically competent in vitro (Day 8 onwards) and in vivo GV oocytes.
To ensure the absence of any contaminating cumulus cells, the zona pellucida was removed by exposing the oocytes to an acid tyrode solution (pH 2.1) (Hogan, 1994) for a short time, and then the oocytes were washed in Leibovitz medium. Oocytes were pooled in groups of five, transferred into cryovials (under controlled visual inspection) and stored at 2808C for gene expression analysis.
Oocyte collection for gene expression during IVM
In vitro collection
For this purpose, a second experiment was carried out. Follicle culture and ovulation induction at the end of culture were performed under conditions similar to those described earlier. Oocytes were collected and analyzed at each developmental stage [immature GV and mature metaphase II (MII)] from two different groups, as follows: in a first group, follicles were cultured for 8 days. From these Day-8 follicles, some were collected as immature GV oocytes, whereas the remaining follicles were induced to ovulate. Extrusion of polar body in this last set was assessed 16 h later (Day 9), and only mature oocytes at MII stage were collected on Day 9. In a second group, follicles were grown in vitro for 12 days. Some oocytes were collected on Day 12 at the GV stage and their complement 16 h later after stimulation, when they had reached MII stage (Day 13). After removing the zona pellucida, oocytes were frozen in groups of five and stored until the day of RNA extraction.
In vivo collection
As in vivo controls, oocytes from prepubertal mice of two different ages (22 days old and 29 days old) were collected since most literature refers to mice of these ages (i.e. Su et al., 2007) . Ovarian follicles from 22-day-old mice are of a comparable chronological age to those cultured in vitro. Follicles from 29-day-old mice are at a later stage of the first wave of growth and were claimed to have higher developmental competence (Eppig and Schroeder, 1989) . In brief, cumulus cell-enclosed oocytes (immature GV stage) were retrieved from the ovaries of stimulated female mice 48 h after eCG priming (2.5 IU Folligon w ; Intervet; intraperitoneal) by puncturing the largest antral follicles with insulin syringe needles. Cumulus -oocyte complexes (COCs) were washed and cumulus cells removed in Leibovitz L-15 medium by repeated pipetting using very fine glass pipettes. To collect mature oocytes, mice were stimulated by an intraperitoneal hCG injection of 2.5 IU Chorulon w (Intervet) 48 h after eCG priming. Fourteen hours after hCG injection, oviducts were removed and COCs were gently released from the ampulla. COCs were placed in the medium containing hyaluronidase (40 IU/ml) to remove cumulus cells and then washed in Leibovitz L-15. After the removal of cumulus-corona cells, only those oocytes which had extruded the polar body (MII oocytes) were collected. Oocyte diameter was measured and the zona pellucida was removed as mentioned previously. Oocytes were frozen in groups of five and stored at 2808C for further gene expression analysis.
RNA extraction and reverse transcription for oocyte samples
Total RNA was extracted from pools of five oocytes using the total RNA extraction kit (RNeasy; Qiagen, Antwerp, Belgium) and a silica-based column extraction method. A DNAse step was used to remove residual genomic DNA. To normalize for the technical variations among the samples (due to manipulation during RNA extraction and RT procedures), 2 pg of luciferase mRNA (Promega, Leiden, The Netherlands) was added to each sample before extraction and used as an exogenous control. Extracted mRNA was eluted in 14 ml RNAse free water. Six to 10 groups of five oocytes were extracted per culture time point for each independent experiment: (i) during oocyte growth: Days 6, 8, 10, 12 and 14; (ii) during oocyte maturation: Days 8, 9, 12 and 13; and the same for the in vivo condition (oocytes pre-and post-hCG stimulus). Synthesis of cDNA was performed on 12 ml of extracted RNA using TaqMan w Reverse Transcription Reagents (Applied Biosystems, Lennik, Belgium). RNA from each group was supplemented with RT mix containing 7.25 ml of nuclease-free water, 5 ml of 10Â RT buffer, 11 ml of MgCl 2 (25 mM), 10 ml of dNTP (2.5 mM), 2.5 ml of random hexamers (50 mM), 1 ml RNAse inhibitor (20 U/ml) and 1.25 ml of multi-scribed reverse transcriptase (50 U/ml) per sample. Cycling conditions for reverse transcription were as follows: 10 min at 258C, 30 min at 488C and 5 min at 958C. Reaction was carried out in a total volume of 50 ml.
Quantitative real-time PCR
Specific primers for the six genes analyzed here were designed with the Universal Probe Library (Roche, Vilvoorde, Belgium). Primer and probe sequences are shown in Table I . Absolute quantification analysis for oocyte genes was performed in a LightCycler apparatus (LC-480-Roche) using Probes Master Mix (Roche). Each reaction mixture consisted of 2 ml of cDNA and 18 ml of PCR mix containing 10 ml of Probes Master Mix, 2 ml of forward (9 mM) and reverse (9 mM) primer mix, 0.2ml of specific probes (10 mM) and 5.8 ml of nuclease-free water per sample. The PCR protocol used was as follows: 10 min at 958C, followed by 55 cycles at 958C for 10 s and 608C for 30 s and finally, a cooling step at 48C. Reactions were performed in triplicate for each sample. Standard curves for each specific gene were constructed using 10-fold serial dilutions of corresponding synthetic oligo (ranging from 1 to 10 6 copies) and were run in each reaction plate. Quantification of exogenous control was carried out using SYBR Green PCR Master Mix (Roche) and using the PCR protocol described before, followed by the acquisition of the melting curve (958C per 5 s and 608C for 1 min, and a continuous fluorescence measurement). The number of copies for each gene within each sample was normalized in relation to copies of exogenous control measured in the same sample. Reaction mixture was the same as described before. Amounts of mRNA (copies) for luciferase were determined from its standard curve.
Assessment of an endogenous control in oocytes
In order to find an endogenous control to use for the normalization of oocyte transcript during final oocyte growth, levels of two well-known housekeeping genes, Histone2a (H2a) and 18S ribosomal RNA, were assessed in individual GV oocytes. Day-10 and Day-12 single oocytes from in vitro follicle culture were used. Relative amounts and the crossing point values (Cp), which is the cycle number at which fluorescent signal reaches a certain threshold (discarding background fluorescence), were used for gene expression analysis. Primers for H2a and 18S sequences are shown in Table I .
Calculations and statistical analysis
A multi-factor ANOVA analysis followed by multiple comparisons was performed. The factors for the analysis of gene expression during in vitro oocyte growth were gene and day of culture. To analyze gene expression in in vitro meiotically competent oocytes compared with in vivo oocytes, the factors were gene and day of culture/in vivo condition. For the analysis of expression during oocyte maturation, the factors were gene, day of culture and maturation stage. Residual analysis showed that the normality of the data was acceptable after a log-transformation of the data. For the analysis of gene expression between in vitro meiotically competent oocytes and in vivo oocytes, a weighting was performed according to the reciprocal of the variance for each day and in vivo condition. Multiple comparisons were set up and correction for simultaneous hypothesis testing was performed according to Sidak's method for the analysis of gene expression during in vitro oocyte growth and during oocyte maturation and according to Dunnet's method for the analysis of in vitro meiotically competent oocytes compared with in vivo oocytes. Correlations were analyzed by Spearman's r. An endogenous control is commonly used to compensate for differences in the amount of total RNA added to each reaction and to correct for sample-to-sample variations due to technical manipulation. Histone2a has been reported as a suitable internal standard for oocyte and preimplantation embryos in bovine and mouse (Robert et al., 2002; Lequarre et al., 2004; Jeong et al., 2005; Pan et al., 2005; . Likewise, 18S rRNA has been used as an endogenous control in different cell types. Given that none of these two transcripts were demonstrated to be optimal endogenous standards and that their use may lead to a bias in the results of our study, we opted for the use of an exogenous control. Results are expressed as the amount of oocyte transcripts per oocyte and are normalized to the exogenous control luciferase, which compensates for the technical variation between the samples.
Oocyte diameter at different stages of in vitro development
Diameters of oocytes at the different stages considered for gene expression analysis ranged from 68 mm (Day 6) to 74 mm (Day 10) (median values) (Fig. 2) . As expected, oocyte diameters from the late pre-antral stage analyzed on Day 6 (from diffuse D follicles) were significantly smaller (P , 0.001) compared with those from antral stages of development (Day 8 onwards). Oocytes in Day-6 follicles, which started antrum formation (D/A follicles), were significantly smaller than those in Day-10, -12 and -14 follicles (P , 0.001) (Fig. 2) . From Day 10 onwards, oocytes reached their maximal diameter and had comparable sizes. There was an inverse relationship between diameter and abundance of specific mRNA: mRNA was lower in oocytes with larger diameters (Fig. 2) . A high variability in oocyte diameter was found between oocytes at the same developmental stage. Diameters of in vivo oocytes were significantly greater (on average 85.7 mm) than in vitro oocytes from all different groups (P , 0.001).
Quantification of oocyte-specific genes during follicle culture
The six selected genes were expressed in oocytes at all stages of in vitro follicular development. A high variability in transcript levels per oocyte was found at all stages of in vitro growth. A comparable pattern of mRNA expression was observed for all transcripts analyzed, although some differences were noticed.
Highest levels of expression of the six oocyte transcripts were found in oocytes from the late pre-antral follicles at Day 6 of development (Fig. 3) . Oocytes from cultured Day-8 follicles were found to have comparable mRNA levels with those from Day 6 (D and D/A). From Day 8 onwards, there was a significant decrease (P , 0.05) of Bmp-15, Gdf-9 and Mater (Fig. 3a-c) . Although Zar-1, Fgf-8 and Npm-2 appear to have a similar pattern, transcript levels were not significantly reduced from Day 8 onwards; levels on Day-10, -12 or -14 oocytes, however, were significantly lower compared with oocytes from the pre-antral follicles (Day 6). By Day 12 and 14, most of the transcripts reached their nadir (Fig. 3) .
Amounts of Bmp-15, Gdf-9, Mater and Npm-2 decreased (P , 0.05) 2.7 to 5 times during development from Day 6 (D follicles) to Day 10, 12 or 14 (Fig. 3) .
Transcript levels for Bmp-15 and Gdf-9 significantly declined 2.3-and 2.6-fold, respectively, from Day 8 to Day 10; and 2.5-and 2.6-fold, respectively from Day 8 to Day 12 (P , 0.05) (Fig. 3a and b) . Levels of Mater significantly decreased 2.9-, 3.2-and 3.9-fold from Days 8 to 10, 12 and 14, respectively (P , 0.05) (Fig. 3c) .
Expression levels between all oocyte-specific genes at all stages of in vitro development were found to be positively correlated (Spearman's r values ranged from 0.75 to 1), with the exception of gene expression in Day-6 oocytes from D/A follicles.
Comparison of oocyte gene expression during follicle culture to pre-ovulatory oocytes from PMSG-stimulated adult mice mRNA abundance in oocytes from the different in vitro grown meiotically competent stages (Days 8, 10, 12 and 14) was compared with mRNA levels in pre-ovulatory in vivo grown oocytes from PMSG-treated adult mice (considered the most competent group) (Fig. 4) . Oocytes from the in vitro Day 14 and the in vivo condition (preovulatory stage follicles) showed the most homogenous mRNA expression for all oocyte genes studied (Fig. 4) .
For five transcripts (Bmp-15, Gdf-9, Mater, Zar-1 and Fgf-8), the mean expression levels found in in vivo oocytes were more comparable with those obtained after 8 days of in vitro culture (Fig. 4a -c, e and f) , whereas for Npm-2, in vivo levels were more comparable with Day 10 (Fig. 4d ) from in vitro. On Day 10, transcript levels for Bmp-15, Mater, Zar-1 and Fgf-8 were found to be expressed in significantly lower amounts compared with in vivo oocytes (P , 0.05). On Day 12, values tend to be lower than in vivo oocytes; however, only Bmp-15 was significantly lower (P , 0.05). On Day 14, the amount of mRNA for all transcripts with the exception of Npm-2 was significantly lower compared with in vivo oocytes (P , 0.05) (Fig. 4) .
Gene expression changes induced by oocyte maturation
Given that in the previous experiment levels of Bmp-15, Gdf-9 and Mater were found to be significantly decreased from Day 8 to Days 10 and 12 (2-to 3-fold), we analyzed the levels of these transcripts during oocyte maturation in in vitro grown oocytes and in vivo controls (Fig. 5) . In cultured follicles (right panel of Fig. 5 ), ovulation response was induced at Days 8 and 12 of culture and extrusion of polar body recorded 16 h later. For in vivo controls, we used GV and MII oocytes from superovulated prepubertal mice at two ages: 22 and 29 days old.
Abundance of Bmp-15 and Gdf-9 transcripts in oocytes from both in vivo age groups was not decreased by the oocyte maturation trigger (left panel of Fig. 5a and b) . Mater levels, however, decreased significantly (P , 0.05) from GV to MII (2.7-fold) in oocytes from 22-day-old but not in those from 29-day-old females (Fig. 5c ).
Of the cultured follicles, Bmp-15, Gdf-9 and Mater oocyte transcript levels were uniformly decreased during maturation from Day 8 to Day 9 (P , 0.05); however, from Day 12 to Day 13, only Mater was found to decrease significantly (P , 0.05). The decrease of mRNA after hCG was more significant from Day 8 to Day 9 (up to 5-fold) than from Day 12 to Day 13 (2.8-fold for Mater) (Fig. 5) .
Transcript levels were also compared between in vitro and in vivo oocytes in the two different maturational stages (GV or MII). Significantly higher amounts of Bmp-15 and Gdf-9 were found in GV oocytes from cultured Day 8 compared with both in vivo conditions (P , 0.05). In vitro levels of Mater on Day 8 were higher than in vivo 29-day-old oocytes; however, levels on Day 12 oocytes were significantly lower compared with both in vivo controls (P , 0.05). As shown in the first experiment, levels of the three transcripts in GV oocytes cultured for 8 days were for a second time found to be significantly higher than in oocytes from Day 12 (P , 0.05) (Fig. 5) .
When levels in MII oocytes were compared between in vitro and in vivo, Bmp-15 and Gdf-9 on Day 13 oocytes were significantly lower compared with in vivo oocytes from 29-day-old but not 22-day-old mice. The amount of Mater on Day 13 was lower than in in vivo oocytes from the two different ages. mRNA amounts for the three genes in MII oocytes from Day 9 were similar to in vivo. Within the in vitro conditions, Day-9 oocytes expressed significantly higher levels of Gdf-9 and Mater than Day-13 oocytes.
Discussion
Oocyte-specific gene expression during follicle culture
It is well known that high amounts of mRNA are synthesized at the earliest stages of oogenesis. This synthesis decreases by the end of oocyte growth (from antral to pre-ovulatory follicles) (Moore and Lintern-Moore, 1978; Bachvarova, 1985; De La Fuente and Eppig, 2001) . At the time of ovulation, the oocyte becomes basically transcriptionally inactive (Kaplan et al., 1982; Eichenlaub-Ritter and Peschke, 2002) .
In mouse oocytes, Gdf-9, Bmp-15, Fgf-8, Mater, Zar-1 and Npm-2 are expressed from the primary or secondary follicular stage onwards (McGrath et al., 1995; Valve et al., 1997; Dube et al., 1998; Burns et al., 2003; Wu et al., 2003a, b; Tong et al., 2004) . So far, however, there are no reports precisely describing the specific dynamics of the six oocyte-specific transcripts during the developmental stages ranging from late pre-antral to large antral stages in vitro.
For the six genes analyzed, the highest level of mRNA expression was detected in oocytes at late pre-antral stage (Day-6 D follicles). A limited drop (1.5-fold) in transcript levels in oocytes coincides with the onset of antrum formation (Day-6 D/A follicles) (Fig. 3) . This is in agreement with Pan et al., 2005 , who studied global changes in gene expression during in vivo oocyte growth. In the latter study, a number of genes differentially expressed were reported to be downregulated by !2-fold at the transition from antrum formation, a time point coinciding with the acquisition of oocyte meiotic competence. Considering that antrum formation is a complex process and that oocyte-secreted factors such as Bmp-15, Gdf-9 and Fgf-8 stimulate the proliferation and differentiation of granulosa cells (Valve et al., 1997; Elvin et al., 1999; Wu and Matzuk, 2002) , we believe that Day-8 oocytes still produce higher mRNA levels compared with later stages for proper completion of their growth.
A decrease in relative abundance of transcripts (2-fold) has been described as the major change occurring during the transition from small to large antral stage of development, which coincides with the acquisition of oocyte developmental competence (Pan et al., 2005) . Accordingly, the following stages of oocyte final growth indicate a shutdown in mRNA expression for Bmp-15, Gdf-9 and Mater from Day 8 of follicle growth onwards (up to 3.9-fold decrease), and by Day 14, transcripts abundance was lowest. Despite their role in early embryogenesis and oocyte-to-embryo transition (Tong et al., 2000) , Mater, Npm-2 and Zar-1 seem to share a similar pattern of expression to those of Bmp-15 and Gdf-9, which, in addition to their role as growth factors, regulate key genes responsible for cumulus expansion at the moment of ovulation (Elvin et al., 1999; Gilchrist et al., 2004) . This may indicate that irrespective of their function, Figure 5 Relative quantification of total mRNA (mean + SEM) for Bmp-15 (a), Gdf-9 (b), Mater (c) in immature (GV) and mature (MII) oocytes from in vitro and in vivo samples (22-and 29-day-old prepubertal mice oocytes). Data are normalized to the amount of exogenous control luciferase. Relative amount is expressed as proportion of the average expression observed on Day 12 of culture (the calibrator). The asterisk indicates differences between GV and MII (P , 0.05). Capitals letters indicate differences in relative expression between in vitro and in vivo GV oocytes (P , 0.05). Small letters indicate differences in relative expression between in vitro and in vivo MII oocytes (P , 0.05).
the silencing of transcriptional activity similarly affects the six transcripts during oocyte growth.
A high variability in both oocyte size and the amount of mRNA per oocyte was found in all in vitro stages. This could be attributed to the heterogeneity in somatic cell proliferation during culture given that oocyte diameter increases discontinuously in relation to follicle remodeling, especially at the onset of antrum formation . We believe that the variations in amounts of mRNA per oocyte may have a similar etiology.
These observations indicate that current culture conditions maintain the expression pattern of six oocyte transcripts selected for their important roles during oocyte and early embryo development.
Oocyte gene expression in vitro compared with in vivo
Comparison of gene expression between in vitro grown oocytes from meiotically competent stages and in vivo grown oocytes from adult mice showed that, for most of the transcripts, oocytes in Day-8 follicles have relative expression levels most comparable with in vivo GV-stage oocytes.
The findings that levels of Bmp-15, Mater, Zar-1 and Fgf-8 on Day 10 were expressed in significantly lower amounts compared with in vivo oocytes and, especially, that Bmp-15 on Day-12 oocytes was lower than in vivo oocytes were surprising, since oocytes from Day 12 had always been considered as optimal under current in vitro culture conditions, based on their maximal capacity to complete meiosis (meiotic competence) . Day-14 oocytes expressed lowest mRNA amounts for almost all genes compared with in vivo, and, from previous studies, we knew that Day-14 oocytes were 'aged', resulting in the inability to reinitiate meiosis after hCG/EGF stimulation . Although the physiological context of 'intrafollicular' aging has been poorly defined, this status could be obtained by a prolonged stimulation phase on an asynchronous cohort of recruited follicles, leading to preovulatory intrafollicular aging of the oocyte. Studies have been conducted in a rat model using delayed ovulation on a large series of animals. The effect of delaying ovulation by 24 or 48 h resulted in significantly more chromosomal abnormalities in the embryos (Butcher and Fugo, 1967) . Likewise, an unsuccessful sperm -oocyte interaction leading to a significant decrease in the percentage of fertilized oocytes and a significant increase in polyspermic zygotes was observed after a 24-h delay in ovulation (Stoker et al., 2003) . In this sense, information from this study might be useful in future culture system development where finding the appropriate moment to induce meiosis is crucial to further normal fertilization and embryogenesis. Mattson and Albertini (1990) initially demonstrated in the mouse that the time of antrum formation coincides with the beginning of what is now known as the surrounded nucleolus (SN) configuration, which in turn correlates with the acquisition of meiotic competence (Wickramasinghe et al., 1991) . It has been demonstrated in the currently used mouse in vitro model that .80% of oocytes show complete SN by Day 8 (Segers et al., submitted for publication), thereby confirming that these oocytes are already competent to resume meiosis (Cortvrindt et al., 1998b) . Research by De La Fuente and Eppig (2001) has shown that when 10-day cultured mouse oocytes-granulosa cell complexes are maintained in transcriptionally inactive prophase arrest for an additional 4 or 6 days, this significantly reduces oocyte developmental competence, but not meiotic competence. Extrapolating De La Fuente's findings to our model, it can be assumed that Day-12 and -14 oocytes have remained for too long in a transcriptionally inactive stage. It has still to be determined whether extending the time in GV arrest in our mouse model relates to altered expression levels of transcripts in an in vivo situation and whether it is indeed related to an intrinsically poor developmental competence.
Taking into account that oocyte transcript levels on Day 8 are more comparable with the in vivo level, current findings indicate that there may be no improvement in maturation capacity by extending the culture too long after Day 8, although the regulation of protein synthesis, stability and turnover might still require some time before it becomes optimal.
Gene expression during in vitro and in vivo oocyte maturation
Oocyte-specific gene expression during meiotic maturation has been widely studied in different species including rodents; however, changes in mRNA amount induced during meiosis have never been analyzed in oocytes from cultured follicles. We also studied gene expression under in vivo oocyte maturation using mice at two different ages. Twenty-two-day-old prepubertal mice were chosen since most literature on oocyte gene expression in mouse refers to animals of this age. Oocytes from 29-day-old mice (late phase of the first wave of growth) were also considered since oocytes of about this age (24 -28 days old) have been reported to be of a higher developmental competence compared with those obtained from younger females (i.e. 16 or 23 days old) (Eppig and Schroeder, 1989) .
It is well known that the oocyte accumulates a large number of transcripts during its growth, while transcriptional activity ceases at the time of meiotic resumption (Bachvarova, 1985) . Nonetheless, the fate of individual transcripts stored in the oocyte can differ during maturation, as some become polyadenylated and are recruited for translation, whereas others are de-adenylated or degraded in a highly controlled and orchestrated fashion (Paynton and Bachvarova, 1994; Eichenlaub-Ritter and Peschke, 2002) .
This study demonstrated that total (polyadenylated and nonpolyadenylated) mRNA expression of Gdf-9, Bmp-15 and Mater decreased significantly after IVM when ovulation was induced on Day 8 (up to 5-fold decrease), but not on Day 12 with the exception of Mater. These findings agree with those of Su et al. (2007) . Besides, lower levels of polyadenylated Bmp-15 were found to be expressed in mouse oocytes matured in vivo compared with immature ones .
Depending on the mRNA type analyzed (polyadenylated or not polyadenylated), a different pattern of expression can be observed for some oocyte transcripts; for example, bovine polyadenylated levels of Gdf-9, Zar-1 and Mater are upregulated in the immature GV stage compared with mature MII oocytes, whereas Bmp-15 is not altered during IVM (Lequarre et al., 2004; Fair et al., 2007; Thélie et al., 2007) . Conversely, when total Gdf-9, Zar-1 and Mater mRNA was analyzed, the three transcripts were expressed in comparable amounts in MII and GV oocytes (Lequarre et al., 2004; Oocyte gene expression in cultured follicles et al., 2007) . Therefore, compared with the aforementioned data, our results on in vitro cultured oocytes are in line with Su et al. (2007) , who analyzed total mRNA expression in in vivo oocytes.
A quite unexpected finding was that in prepubertal animals, oocyte maturation in vivo showed some conflicting results. In contrast to a down-regulation of transcripts as seen in in vitro oocytes, the levels of Bmp-15 and Gdf-9 remained stable in the 22-and 29-day-old prepubertal female oocytes, whereas the levels of Mater decreased significantly, but only in oocytes from 22-day-old mice. Analysis of RNA synthesis through BrU incorporation into nascent RNA has demonstrated that there is no difference in transcriptional activity between oocytes from prepubertal mice at different ages or even when compared with oocytes from adult mice (Bouniol-Baly et al., 1999) . Our results on gene expression of these three transcripts confirm previous findings. Nonetheless, although levels of Mater in GV and MII oocytes from 22-and 29-day-old mice were similar, it was interesting to note that the pattern of expression of this gene during oocyte maturation differed for the two age groups. This may suggest that there are differences in gene expression pattern for some particular genes during oocyte maturation depending on the age of the female induced to ovulate. Whether differences in gene expression pattern influence the quality of the oocyte is not known. Furthermore, if we compare our in vitro results in transcript levels with their in vivo counterparts, MII oocytes from Day 13, but not Day 9, expressed significantly lower amounts of Bmp-15 and Gdf-9 compared with oocytes from 29-day-old but not with 22-day-old prepubertal mice, whereas Mater expression in Day 13 was lower than the two in vivo conditions. This suggests that MII oocytes obtained on Day 9 of culture are most comparable with those of the in vivo condition and might be of a better developmental potential. Su et al. (2007) reported that oocyte transcripts significantly decreased during oocyte maturation; however, expression patterns found for Bmp-15 and Gdf-9 in oocytes from both ages of prepubertal mice are in discrepancy. To explain these differences in gene expression, it should first be considered that GV oocytes from antral follicles developed in vivo are isolated manually and arbitrarily, whereas in a natural ovulation process, oocytes are selectively ovulated depending on a precisely regulated follicular constitution. Therefore, it is likely that the population of oocytes triggered to ovulate by hCG differs from the population available for arbitrary retrieval after ovarian stimulation with eCG. In spite of a presumably rigorous selection procedure, differences observed between these results and those by Su et al. (2007) may be related to the selection of antral follicles used for gene expression analysis. In both studies, large antral follicles were punctured after ovarian eCG stimulation; however, in an attempt to limit the heterogeneity in the quality of the samples, oocytes were selectively isolated from the largest antral follicles in this study. Despite the fact that follicles in both studies seem to be of a similar origin, the numbers of oocytes obtained per ovary in the Su et al.'s report (approximately 50 oocytes/animal) is much higher than in the present study (15 -20 oocytes/animal). The data from the in vitro set up in this paper demonstrate that oocytes from Day-8 follicles express significantly higher transcript levels than Day-12 oocytes and that a clear drop in transcription became more pronounced during meiotic maturation of oocytes from earlier development stages (Day 8 to 9 compared with Day 12 to 13). Therefore, we speculate that the more follicles or oocytes are retrieved from an ovary, the higher will be the chance of including oocytes from follicles at an earlier stage of development. As a result, the 'apparently' discrepant results with Su et al. (2007) can be accounted for as a purely technical question.
This study demonstrates that, depending on the culture time, in vitro grown oocytes can contain equally high transcript levels as in vivo grown oocytes. In quantitative terms, mRNA expression level on Day 8 of culture seemed most similar to the in vivo group from which it is known that most oocytes develop into normal offspring, whereas expression levels in oocytes collected after Day 8 were reduced. Administration of the ovulatory stimulus in control mice differing by age (22 and 29 days) induced a different mRNA expression pattern. Considering that current gene selection has already been related to normal embryo development in vivo, our further experiments should prospectively evaluate embryonic development and implantation capacity of in vitro oocytes from follicles cultured for 9 versus 13 days. 
